Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
ANTX on Nasdaq
Robin Shane Readnour - trading volume in the past year for AN2 Therapeutics, Inc.
Holdings reported by Robin Shane Readnour for AN2 Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
653K |
$975K |
$1.49 |
Dec 10, 2024 |
Indirect |
|
|
| Stock Option (Right to Buy) |
64.5K |
|
|
Jun 19, 2024 |
Direct |
Common Stock |
|
Transactions reported by Robin Shane Readnour for AN2 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.